Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Oesophagogastric Cancer × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 22 Colorectal Neoplasms 18 Rectal Neoplasms 10 Stomach Neoplasms 8 Colonic Neoplasms 8 Carcinoma, Hepatocellular 7 Neoplasm Metastasis 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Liver Neoplasms 5 Uterine Cervical Neoplasms 4 Osteosarcoma 4 Urinary Bladder Neoplasms 3 Neuroblastoma 3 Multiple Myeloma 3 Lung Neoplasms 3 Locally Advanced Rectal Cancer 3 Kidney Neoplasms 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3 Turcot syndrome 2 Squamous Cell Carcinoma of Head and Neck 2 Peritoneal Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Inflammatory Breast Neoplasms 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡